Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesalazine mucosal concentration comparison in mild to moderate ulcerative colitis
2016-000516-15Phase 4Completed
- Sponsor
- Consorzio Universitario UNIFARM
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of Salcrozine in autoimmune colitis (3 arms), sponsored by Consorzio Universitario UNIFARM. Primary endpoint: Tissue concentrations in endoscopic intestinal biopsies of different mesalazine formulations. Started Dec 2020; status: completed.
02
Drugs
Salcrozine
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on 2016-000516-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000516-15.